Liposomal amphotericin B standard dose in combination with caspofungin versus liposomal amphotericin B high dose regimen for the treatment of invasive aspergillosis in immunocompromised patients:: randomised pilot study (Combistrat Trial)

被引：0
|
作者：
Caillot, D.
Thiebaut, A.
Herbrecht, R.
Pigneux, A.
de Botton, S.
Attal, M.
Bernard, F.
Larche, J.
Alfandari, S.
Monchecourt, F.
Mahi, L.
机构：
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2007年 / 29卷
关键词：
D O I：
10.1016/S0924-8579(07)70821-X
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S260 / S260
页数：1
相关论文
共 50 条
  • [21] Comparison of the efficacy of combination and monotherapy with caspofungin and liposomal amphotericin B against invasive candidiasis
    Tunger, Ozlem
    Bayram, Bahm
    Degerli, Kenan
    Dinc, Gonul
    Cetin, Banu C.
    SAUDI MEDICAL JOURNAL, 2008, 29 (05) : 728 - 733
  • [22] Massive intracerebral aspergillosis responding to combination high dose liposomal amphotericin B and cytokine therapy without surgery
    Ellis, M
    Watson, R
    McNabb, A
    Lukic, ML
    Nork, M
    JOURNAL OF MEDICAL MICROBIOLOGY, 2002, 51 (01) : 70 - 75
  • [23] Treatment Strategies for Invasive Aspergillosis in Neutropenic Patients: Voriconazole or Liposomal Amphotericin-B?
    Pagano, L.
    Valentini, C. G.
    Fianchi, L.
    Caira, M.
    JOURNAL OF CHEMOTHERAPY, 2011, 23 (01) : 5 - 8
  • [24] Treatment of suspected and proven systemic mycoses in neutropenic patients with a combination of liposomal amphotericin B and caspofungin
    Lindauer, M
    Kolbe, K
    Huber, C
    Ullmann, A
    BONE MARROW TRANSPLANTATION, 2002, 29 : S248 - S248
  • [25] Treatment of visceral leishmaniasis with liposomal amphotericin B in three immunocompromised patients
    Rodríguez-Wilhelmi, P
    Panizo, C
    Ruza, E
    Rocha, E
    MEDICINA CLINICA, 2001, 116 (01): : 37 - 38
  • [26] Efficacy of high doses of liposomal amphotericin B in the treatment of experimental aspergillosis
    Martín, MT
    Gavaldà, J
    López, P
    Gomis, X
    Ramírez, JL
    Rodríguez, D
    Len, O
    Jordano, Q
    Ruiz, I
    Rosal, M
    Almirante, B
    Pahissa, A
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (06) : 1032 - 1034
  • [27] Liposomal Amphotericin B as Initial Therapy for Invasive Mold Infection: A Randomized Trial Comparing a High-Loading Dose Regimen with Standard Dosing (AmBiLoad Trial)
    Fortun Abete, Jesus
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2016, 29 : 13 - 16
  • [28] Liposomal amphotericin B as initial therapy for invasive mold infection: A randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)
    Cornely, Oliver A.
    Maertens, Johan
    Bresnik, Mark
    Ebrahimi, Ramin
    Ullmann, Andrew J.
    Bouza, Emilio
    Heussel, Claus Peter
    Lortholary, Olivier
    Rieger, Christina
    Boehme, Angelika
    Aoun, Mickael
    Horst, Heinz-August
    Thiebaut, Anne
    Ruhnke, Markus
    Reichert, Dietmar
    Vianelli, Nicola
    Krause, Stefan W.
    Olavarria, Eduardo
    Herbrecht, Raoul
    CLINICAL INFECTIOUS DISEASES, 2007, 44 (10) : 1289 - 1297
  • [29] Pharmacoeconomic evaluation of caspofungin versus liposomal amphotericin B in empirical treatment of invasive fungal infections in Turkey
    Turner, S. J.
    Senol, E.
    Kara, A.
    Al-Badriyeh, D.
    Kong, D. C. M.
    Dinleyici, E. C.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 (03) : 276 - 280
  • [30] Safety and tolerance of liposomal amphotericin B in the treatment of invasive aspergillosis in a neutropenic adolescent
    Gandemer, V
    Taque, S
    Guiguen, C
    Rambeau, M
    Sayagh, M
    Le Gall, E
    JOURNAL DE MYCOLOGIE MEDICALE, 2000, 10 (02): : 105 - 107
12345